Opinion on Cardiovascular and Diabetes

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

DuPont / Kos Pharmaceuticals: a good combination for dyslipidemia

Published By Datamonitor
28 Sep 2000
CommentWire
CommentWire

Vitamin C: benefits of supplements still in question

Published By Datamonitor
05 Oct 2000
CommentWire
CommentWire

Anti-platelets: NICE ruling for Merck and Co

Published By Datamonitor
11 Oct 2000
CommentWire
CommentWire

Statins: new data, same game for BMS

Published By Datamonitor
18 Oct 2000
CommentWire
CommentWire

Pfizer: still growing fast, despite Lipitor blip

Published By Datamonitor
27 Oct 2000
CommentWire
CommentWire

Glaxo Wellcome: taking some of the tension out of anti-hypertension

Published By Datamonitor
01 Nov 2000
Expert View
Expert View

Compliance is just a click away

Published By Datamonitor
03 Nov 2000
CommentWire
CommentWire

Roche: is Xenical a panacea for the obese?

Published By Datamonitor
07 Nov 2000
CommentWire
CommentWire

Raisio: Benecol isn't beneficial to the bottom line

Published By Datamonitor
09 Nov 2000
Expert View
Expert View

The price of a premium product

Published By Datamonitor
10 Nov 2000

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.